Mutual Fund Details

DSP Healthcare Fund Direct-IDCW

Equity Pharma

NAV

₹23.9330

as on 15 Apr 2024, 09:00 PM

₹-0.2380(0.98%)

Last Change

Schemes Managed By

Chirag Dagli

Investment Performance

would have given a return of

₹1,10,871

₹1,21,647

₹1,61,492

₹1,68,309

Bank Account

Fixed Deposit

Regular Mutual Fund

This Fund on Paytm Money

This Mutual Fund

₹68,309

Profit (absolute return)

68.31%

in the last

max

+1% Higher Returns

With Direct Plans on Paytm Money

Investment Returns

In the last 3 months

6.85%

In the last 6 months

24.43%

In the last 1 year

53.12%

In the last 3 years

68.31%

In the last 5 years

237.20%

In the last 10 years

Absolute Returns

CAGR

Scheme Riskometer

low

low to moderate

moderate

moderately high

high

very high

Investors understand that their principal will be at very high risk

Scheme Information

DSP Healthcare Fund Direct-IDCW

as of 31 Mar 2024, 05:30 AM

₹2,352.32 Cr

Scheme Asset Size

Fund Type

Open-End

Exit Load

Exit load of 0.50% if redeemed within 1 month.

0.65%

Expense Ratio

Plan

Dividend

2.29%

Cash Holding

Benchmark

S&P BSE Healthcare Total Return Index

Scheme Document

View

Benchmark

S&P BSE Healthcare Total Return Index

Exit Load

Exit load of 0.50% if redeemed within 1 month.

Scheme Document

View

Sectors Holding in this Mutual Fund

as on 31 Mar 2024

Sort By

Value

Sector

Healthcare

95.52%

₹2,246.93 Cr

Insurance

1.73%

₹40.70 Cr

Others

2.75%

₹64.69 Cr

Sectors Holding in this Mutual Fund

as on 31 Mar 2024

Sort By

Value

Sector

Healthcare

95.52%

₹2,246.93 Cr

Insurance

1.73%

₹40.70 Cr

Others

2.75%

₹64.69 Cr

Companies Holding in this Mutual Fund

as on 31 Mar 2024

Sort By

Value

Company

Sun Pharmaceutical Industries Ltd.

14.04%

₹330.27 Cr

Ipca Laboratories Ltd.

8.44%

₹198.54 Cr

Suven Pharmaceuticals Ltd.

8.33%

₹195.95 Cr

Cipla Ltd.

8.17%

₹192.18 Cr

Lupin Ltd.

7.51%

₹176.66 Cr

Others

53.51%

₹1,258.73 Cr

View All

Companies Holding in this Mutual Fund

as on 31 Mar 2024

Sort By

Value

Company

Sun Pharmaceutical Industries Ltd.

14.04%

₹330.27 Cr

Ipca Laboratories Ltd.

8.44%

₹198.54 Cr

Suven Pharmaceuticals Ltd.

8.33%

₹195.95 Cr

Cipla Ltd.

8.17%

₹192.18 Cr

Lupin Ltd.

7.51%

₹176.66 Cr

Others

53.51%

₹1,258.73 Cr

View All

Funds in this Category

This fund's returns:

18.93%

Return Duration

3 Years

SBI Healthcare Opportunities Fund Direct Plan-Growth

ICICI Prudential Pharma Healthcare And Diagnostics (P.H.D) Fund Direct - Growth

DSP Healthcare Fund Direct - Growth

About DSP Healthcare Fund Direct-IDCW

DSP Healthcare Fund Direct-IDCW is a Equity mutual fund scheme from DSP Mutual Fund. This scheme was launched on Invalid date and is currently managed by its fund manager Chirag Dagli. It has an AUM of ₹2,352.32 Crores and the latest NAV decalared is ₹23.933 as on 16 Apr 2024 at 1:13 pm.

DSP Healthcare Fund Direct-IDCW scheme return performance in last 1 year is 53.12%, in last 3 years is 68.31% and 250.53% since scheme launch. The min. SIP amount to invest in this scheme is ₹100.